Lukas Biomedical Inc. 6814.TWO Stock
Lukas Biomedical Inc. Price Chart
Lukas Biomedical Inc. 6814.TWO Financial and Trading Overview
| Lukas Biomedical Inc. stock price | 30.7 TWD |
| Previous Close | 35.4 TWD |
| Open | 35.4 TWD |
| Bid | 34 TWD x N/A |
| Ask | 34.75 TWD x N/A |
| Day's Range | 33.2 - 36 TWD |
| 52 Week Range | 25.6 - 43.3 TWD |
| Volume | 277.66K TWD |
| Avg. Volume | 74.38K TWD |
| Market Cap | 1.32B TWD |
| Beta (5Y Monthly) | -0.099022 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.03 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6814.TWO Valuation Measures
| Enterprise Value | 1.4B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.133865 |
| Price/Book (mrq) | 4.025448 |
| Enterprise Value/Revenue | 7.573 |
| Enterprise Value/EBITDA | -54.595 |
Trading Information
Lukas Biomedical Inc. Stock Price History
| Beta (5Y Monthly) | -0.099022 |
| 52-Week Change | 14.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 43.3 TWD |
| 52 Week Low | 25.6 TWD |
| 50-Day Moving Average | 37.76 TWD |
| 200-Day Moving Average | 34.73 TWD |
6814.TWO Share Statistics
| Avg. Volume (3 month) | 74.38K TWD |
| Avg. Daily Volume (10-Days) | 31.98K TWD |
| Shares Outstanding | 36.87M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -27.095% |
| Operating Margin (ttm) | -26.22% |
| Gross Margin | 49.53% |
| EBITDA Margin | -13.87% |
Management Effectiveness
| Return on Assets (ttm) | -5.99% |
| Return on Equity (ttm) | -16.30% |
Income Statement
| Revenue (ttm) | 184.79M TWD |
| Revenue Per Share (ttm) | 5.03 TWD |
| Quarterly Revenue Growth (yoy) | 22.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -25633000 TWD |
| Net Income Avi to Common (ttm) | -50070000 TWD |
| Diluted EPS (ttm) | -1.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 40.26M TWD |
| Total Cash Per Share (mrq) | 1.09 TWD |
| Total Debt (mrq) | 112.22M TWD |
| Total Debt/Equity (mrq) | 34.27 TWD |
| Current Ratio (mrq) | 1.87 |
| Book Value Per Share (mrq) | 8.881 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7436000 TWD |
| Levered Free Cash Flow (ttm) | 8.55M TWD |
Profile of Lukas Biomedical Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 2, Xinyi Road |
| ZIP | 106 |
| Phone | 886 2 2950 0027 |
| Website | https://lukas-bio.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 68 |
Lukas Biomedical Inc. engages in the research and the development of immune cell therapy for cancer treatment. The company operates through three divisions: E-commerce, Medical Management Business, and Cell Product. It develops immune and stem cell medical technologies for regenerative medicine; wholesales and retails cosmetics; and wholesales medical equipment. The company was founded in 2002 and is based in Taipei, Taiwan.
Q&A For Lukas Biomedical Inc. Stock
What is a current 6814.TWO stock price?
Lukas Biomedical Inc. 6814.TWO stock price today per share is 30.7 TWD.
How to purchase Lukas Biomedical Inc. stock?
You can buy 6814.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lukas Biomedical Inc.?
The stock symbol or ticker of Lukas Biomedical Inc. is 6814.TWO.
Which industry does the Lukas Biomedical Inc. company belong to?
The Lukas Biomedical Inc. industry is Biotechnology.
How many shares does Lukas Biomedical Inc. have in circulation?
The max supply of Lukas Biomedical Inc. shares is 37.37M.
What is Lukas Biomedical Inc. Price to Earnings Ratio (PE Ratio)?
Lukas Biomedical Inc. PE Ratio is now.
What was Lukas Biomedical Inc. earnings per share over the trailing 12 months (TTM)?
Lukas Biomedical Inc. EPS is -1.03 TWD over the trailing 12 months.
Which sector does the Lukas Biomedical Inc. company belong to?
The Lukas Biomedical Inc. sector is Healthcare.